Holly Yu

1.4k total citations
57 papers, 1.0k citations indexed

About

Holly Yu is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Holly Yu has authored 57 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 25 papers in Epidemiology and 16 papers in Surgery. Recurrent topics in Holly Yu's work include Clostridium difficile and Clostridium perfringens research (19 papers), Microscopic Colitis (18 papers) and Surgical site infection prevention (13 papers). Holly Yu is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (19 papers), Microscopic Colitis (18 papers) and Surgical site infection prevention (13 papers). Holly Yu collaborates with scholars based in United States, Germany and United Kingdom. Holly Yu's co-authors include Reiko Sato, Kathleen W. Wyrwich, Joel Bobula, Sharon A. Welner, Hanane Khoury, Douglas Girgenti, Anique Ducharme, Marie‐Claude Guertin, Philippe L. L’Allier and Jean-Claude Tardif and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Journal of the American College of Cardiology.

In The Last Decade

Holly Yu

52 papers receiving 1000 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Holly Yu United States 19 320 255 244 173 131 57 1.0k
Joseph John India 18 128 0.4× 191 0.7× 407 1.7× 274 1.6× 189 1.4× 80 1.8k
Amit Banga United States 20 281 0.9× 257 1.0× 445 1.8× 98 0.6× 43 0.3× 93 1.5k
Yizhak Kupfer United States 14 756 2.4× 130 0.5× 143 0.6× 109 0.6× 471 3.6× 92 1.5k
H. Schäfer Germany 17 322 1.0× 136 0.5× 144 0.6× 159 0.9× 66 0.5× 47 1.3k
Jean–Pierre Marmuse France 27 395 1.2× 146 0.6× 1.6k 6.4× 244 1.4× 126 1.0× 68 2.3k
Emma Espinosa Italy 13 150 0.5× 64 0.3× 60 0.2× 275 1.6× 81 0.6× 17 865
Scott W. Mueller United States 21 269 0.8× 317 1.2× 143 0.6× 98 0.6× 19 0.1× 80 1.1k
Ramasubbareddy Dhanireddy United States 26 546 1.7× 130 0.5× 303 1.2× 36 0.2× 96 0.7× 69 2.1k
M. Schilling United States 20 881 2.8× 169 0.7× 271 1.1× 56 0.3× 18 0.1× 50 1.6k
Ruben Bromiker Israel 18 207 0.6× 83 0.3× 243 1.0× 42 0.2× 38 0.3× 56 1.4k

Countries citing papers authored by Holly Yu

Since Specialization
Citations

This map shows the geographic impact of Holly Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly Yu more than expected).

Fields of papers citing papers by Holly Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holly Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly Yu. The network helps show where Holly Yu may publish in the future.

Co-authorship network of co-authors of Holly Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Holly Yu. A scholar is included among the top collaborators of Holly Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holly Yu. Holly Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vietri, Jeffrey, et al.. (2024). Preferences for a Clostridioides difficile vaccine among adults in the United States. Vaccine. 42(24). 126261–126261.
2.
Brestrich, Gordon, et al.. (2024). Excess Healthcare Costs and Resource Utilisation of Lyme Borreliosis in Germany: A Propensity Score–Matched Cohort Study. Zoonoses and Public Health. 72(1). 23–31. 3 indexed citations
3.
Brestrich, Gordon, Nils Kossack, James H. Stark, et al.. (2024). Incidence of Lyme Borreliosis in Germany: A retrospective observational healthcare claims study. Ticks and Tick-borne Diseases. 15(3). 102326–102326. 9 indexed citations
4.
Yu, Holly, Tamuno Alfred, Jingying Zhou, Jennifer Judy, & Margaret A. Olsen. (2024). Incidence, healthcare and out-of-pocket costs, and mortality of Clostridioides difficile infection among US adults aged 18 to 64 years. SHILAP Revista de lepidopterología. 4(1). e215–e215.
5.
Olsen, Margaret A., Matthew Keller, Dustin Stwalley, Holly Yu, & Erik R. Dubberke. (2023). Increased Incidence and Risk of Septicemia and Urinary Tract Infection After Clostridioides difficile Infection. Open Forum Infectious Diseases. 10(8). ofad313–ofad313. 2 indexed citations
6.
Brestrich, Gordon, Frederick J. Angulo, Fabian K. Berger, et al.. (2023). Epidemiology of Clostridioides difficile Infections in Germany, 2010–2019: A Review from Four Public Databases. Infectious Diseases and Therapy. 12(4). 1057–1072. 5 indexed citations
7.
Sahrmann, John M., Margaret A. Olsen, Matthew Keller, Holly Yu, & Erik R. Dubberke. (2023). Healthcare Costs of Clostridioides difficile Infection in Commercially Insured Younger Adults. Open Forum Infectious Diseases. 10(7). 3 indexed citations
8.
Munjal, Iona, Jill Dreyfus, Holly Yu, et al.. (2022). Staphylococcus aureus infections after elective pediatric surgeries. Infection Control and Hospital Epidemiology. 43(11). 1625–1633. 1 indexed citations
9.
Yu, Holly, et al.. (2020). Assessing risk factors, mortality, and healthcare utilization associated with Clostridioides difficile infection in four Latin American countries. The Brazilian Journal of Infectious Diseases. 25(1). 101040–101040. 8 indexed citations
10.
Wilke, Thomas, et al.. (2020). Burden of Staphylococcus aureus infections after orthopedic surgery in Germany. BMC Infectious Diseases. 20(1). 233–233. 12 indexed citations
11.
Rashid, Nazia, et al.. (2019). Culture-Confirmed Staphylococcus aureus Infection after Elective Hysterectomy: Burden of Disease and Risk Factors. Surgical Infections. 21(2). 169–178. 3 indexed citations
12.
Matza, Louis S., Holly Yu, Katherine A. Belden, et al.. (2019). Health state utilities associated with post-surgical Staphylococcus aureus infections. The European Journal of Health Economics. 20(6). 819–827. 16 indexed citations
13.
Harnett, James, et al.. (2018). Impaired Quality of Life, Work, and Activities Among Adults with Clostridium difficile Infection: A Multinational Survey. Digestive Diseases and Sciences. 63(11). 2864–2873. 27 indexed citations
14.
15.
Sato, Reiko, Kathleen W. Wyrwich, John H. Powers, & Holly Yu. (2015). Observational longitudinal study of symptom burden and time for recovery from community-acquired pneumonia reported by older adults surveyed nationwide using the CAP Burden of Illness Questionnaire. Patient Related Outcome Measures. 6. 215–215. 28 indexed citations
16.
Berger, Ariel, John Edelsberg, Holly Yu, & Gerry Oster. (2014). Clinical and Economic Consequences of Post-Operative Infections following Major Elective Surgery in U.S. Hospitals. Surgical Infections. 15(3). 322–327. 9 indexed citations
17.
Kleinman, Nathan L., et al.. (2013). Work-Related and Health Care Cost Burden of Community-Acquired Pneumonia in an Employed Population. Journal of Occupational and Environmental Medicine. 55(10). 1149–1156. 8 indexed citations
18.
Utian, Wulf H., Holly Yu, Joel Bobula, et al.. (2009). Bazedoxifene/conjugated estrogens and quality of life in postmenopausal women. Maturitas. 63(4). 329–335. 82 indexed citations
19.
Mines, Daniel, et al.. (2005). Prevalence of risk factors for suicide in patients prescribed venlafaxine, fluoxetine, and citalopram. Pharmacoepidemiology and Drug Safety. 14(6). 367–372. 33 indexed citations
20.
Tardif, Jean‐Claude, Anique Ducharme, Holly Yu, Jenifer Wogen, & Marie‐Claude Guertin. (2004). Retrospective longitudinal cohort study comparing the effects of angiotensin-converting enzyme inhibitors and long-acting calcium channel blockers on total and cardiovascular mortality in patients with hypertension. Clinical Therapeutics. 26(7). 1073–1083. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph John Breakdown of academic impact, for papers by Amit Banga Breakdown of academic impact, for papers by Yizhak Kupfer Breakdown of academic impact, for papers by H. Schäfer Breakdown of academic impact, for papers by Jean–Pierre Marmuse Breakdown of academic impact, for papers by Emma Espinosa Breakdown of academic impact, for papers by Scott W. Mueller Breakdown of academic impact, for papers by Ramasubbareddy Dhanireddy Breakdown of academic impact, for papers by M. Schilling Breakdown of academic impact, for papers by Ruben Bromiker
Rankless by CCL
2026